QUAD PHARMS
PharmaQUAD PHARMS is a pharmaceutical company focused on Oncology, Dermatology, Gastroenterology.
QUAD PHARMS's Key Drugs
QUAD PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
QUAD PHARMS's Recent FDA Approvals
New NDA/BLA approvals for QUAD PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
QUAD PHARMS's Therapeutic Areas
QUAD PHARMS's approved drugs and pipeline span 5 therapeutic areas, led by Oncology and Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
QUAD PHARMS's Top Competitors
QUAD PHARMS's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Johnson & Johnson, and PF PRISM CV. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
QUAD PHARMS Pipeline Snapshot
Active clinical trials for QUAD PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 106